|
End-of-day quote
Shenzhen S.E.
20/08/2026
|
5-day change | 1st Jan Change | ||
| 8.700 CNY | +4.82% |
|
-0.57% | +9.57% |
| Market Cap | 5.06B 752M 644M 601M 552M 1.04B 71.99B 1.06B 7.13B 2.78B 36.08B 2.83B 2.76B 119B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.89B 727M 623M 581M 533M 1B 69.59B 1.02B 6.89B 2.69B 34.88B 2.73B 2.67B 115B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | +4.82% | ||
| 1 week | -0.57% | ||
| Current month | +11.40% | ||
| 1 month | +13.73% | ||
| 3 months | -2.25% | ||
| 6 months | -13.09% | ||
| Current year | +9.57% |
| 1 week | 8.26 | 8.94 | |
| 1 month | 7.31 | 8.94 | |
| Current year | 7.08 | 11.38 | |
| 1 year | 7.08 | 11.38 | |
| 3 years | 3.58 | 11.98 | |
| 5 years | 3.58 | 11.98 | |
| 10 years | 3.58 | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 11/12/2017 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 01/08/2019 |
Sen Li
COO | Chief Operating Officer | 45 | 25/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 01/08/2019 |
Ying Yang
CHM | Chairman | 48 | 21/03/2019 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 21/03/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.82% | -0.57% | -15.70% | +34.88% | 752M | ||
| -2.81% | +2.93% | +76.40% | +127.73% | 1,109B | ||
| -2.21% | +2.02% | +49.50% | +55.01% | 644B | ||
| -1.56% | +4.39% | +25.19% | +74.39% | 463B | ||
| -1.17% | +3.32% | +39.77% | +44.28% | 371B | ||
| -1.00% | +2.21% | +21.66% | +39.04% | 301B | ||
| -0.56% | +4.99% | -0.13% | +12.72% | 256B | ||
| -1.95% | +3.80% | +46.31% | +65.66% | 234B | ||
| -0.13% | +0.44% | -16.88% | -53.06% | 205B | ||
| -2.82% | +3.84% | +20.81% | +89.04% | 178B | ||
| Average | +0.05% | +2.67% | +24.69% | +48.97% | 376.18B | |
| Weighted average by Cap. | -0.15% | +3.26% | +42.70% | +70.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 146M 125M 117M 107M 201M 13.99B 205M 1.39B 540M 7.01B 549M 537M 23.22B | 1.21B 179M 153M 143M 131M 247M 17.15B 252M 1.7B 662M 8.59B 673M 658M 28.45B |
| Net income | 13.65M 2.03M 1.74M 1.62M 1.49M 2.8M 194M 2.85M 19.24M 7.5M 97.33M 7.62M 7.46M 322M | 92.73M 13.79M 11.8M 11.01M 10.11M 18.99M 1.32B 19.36M 131M 50.94M 661M 51.77M 50.64M 2.19B |
| Net Debt | 189M 28.11M 24.07M 22.46M 20.61M 38.72M 2.69B 39.48M 266M 104M 1.35B 106M 103M 4.46B | -169M -25.1M -21.49M -20.05M -18.4M -34.57M -2.4B -35.25M -238M -92.72M -1.2B -94.24M -92.19M -3.98B |
Employees
1,188
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | CN¥8.700 | +4.82% | 34,083,999 |
| 19/08/26 | CN¥8.300 | -3.38% | 16,649,500 |
| 18/08/26 | CN¥8.590 | -1.38% | 15,169,100 |
| 17/08/26 | CN¥8.710 | -0.23% | 20,696,400 |
| 14/08/26 | CN¥8.730 | -0.23% | 22,324,100 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
















